Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432M
-
Number of holders
-
221
-
Total 13F shares, excl. options
-
261M
-
Shares change
-
+13.9M
-
Total reported value, excl. options
-
$9.42B
-
Value change
-
+$494M
-
Put/Call ratio
-
0.29
-
Number of buys
-
115
-
Number of sells
-
-111
-
Price
-
$36.14
Significant Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q3 2021
276 filings reported holding RPRX - Royalty Pharma plc - Common Stock as of Q3 2021.
Royalty Pharma plc - Common Stock (RPRX) has 221 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 261M shares
of 432M outstanding shares and own 60.36% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (57.3M shares), VANGUARD GROUP INC (30M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (24.7M shares), FMR LLC (19.1M shares), BlackRock Inc. (15.5M shares), Berkshire Hathaway Inc (13.1M shares), Vantage Consulting Group Inc (7.86M shares), HARVARD MANAGEMENT CO INC (7.14M shares), SIGULER GUFF ADVISERS, LLC (6.76M shares), and STATE STREET CORP (5.83M shares).
This table shows the top 221 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.